Trending...
- Pray the News Launches to Transform American Christians' Relationship with News
- Lottery.com Inc. Secures $300 Million in Growth Capital, Confirms Nasdaq Compliance & Acquires UAE Sports Incubator Amid High-Profile Brand Exposure
- $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
DENVER - PrAtlas -- Sploot Veterinary Care, a leading provider of modern and advanced veterinary care, today announced an exclusive regional U.S. partnership with DeepScan Diagnostics, the innovator behind the world's most advanced and comprehensive cell-free DNA (cfDNA) screening tests for pets. This collaboration brings DeepScan's non-invasive, early detection test—already successfully utilized in Europe—to the U.S. market for the first time, and only through Sploot.
DeepScan's CFD (cell-free DNA) test identifies hidden signs of disease before symptoms appear—empowering pet parents with early, actionable insights. By detecting conditions like cancer, chronic inflammation, and organ damage earlier than traditional blood work, this technology enables earlier intervention, more treatment options, and better outcomes. Through this trailblazing approach, Sploot continues to redefine veterinary care by making advanced diagnostics more accessible and effective for pet parents.
More on PrAtlas
"We are excited to bring this breakthrough screening technology to pet parents in Colorado and Illinois" said Yoav Mordowicz, Co-Founder and Co-CEO at Sploot. "This partnership is a natural extension for our commitment to proactive, science-backed care - and it helps us continue redefining what's possible in everyday veterinary wellness, while enhancing the quality and longevity of pets' lives."
With this partnership, Sploot further reinforces its role as a pioneer in adopting next-generation diagnostics and applying precision medicine to everyday pet care.
"Partnering with Sploot was a natural choice for us," said Franz Mittler, Chief Commercial Officer at DeepScan. "Their forward-thinking approach to veterinary care, combined with our innovative screening test, will empower pet parents with vital information that was previously unavailable in the U.S. market."
About Sploot Veterinary Care
Sploot Veterinary Care is redefining the veterinary experience with a modern, pet-parent-first approach. Operating clinics in Denver, Chicago and Colorado Springs, Sploot offers comprehensive services - including primary, urgent, emergency and specialty care – under one roof. As a FearFree practice, Sploot prioritizes reducing pet stress and anxiety during every visit, ensuring a calm and compassionate environment. Their state-of-the-art facilities are open 8am-8pm, 365 days a year, providing same-day appointments and a seamless digital experience. With a focus on transparency, convenience and exceptional care, Sploot is committed to making veterinary services more accessible and stress-free for both pets and their parents.
More on PrAtlas
About DeepScan Diagnostics:
DeepScan Diagnostics is redefining pet healthcare by making early detection accessible, affordable, and transformative. Utilizing advanced, non-invasive cell-free DNA measurements, DeepScan empowers veterinarians and pet parents with precise health screenings, often identifying issues before symptoms appear. With a commitment to extending and enhancing pets' lives through proactive and personalized care, DeepScan is pioneering precision diagnostics and building the largest cfDNA dataset to improve decision-making, treatment options, and peace of mind for both pet parents and veterinary professionals.
DeepScan's CFD (cell-free DNA) test identifies hidden signs of disease before symptoms appear—empowering pet parents with early, actionable insights. By detecting conditions like cancer, chronic inflammation, and organ damage earlier than traditional blood work, this technology enables earlier intervention, more treatment options, and better outcomes. Through this trailblazing approach, Sploot continues to redefine veterinary care by making advanced diagnostics more accessible and effective for pet parents.
More on PrAtlas
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
"We are excited to bring this breakthrough screening technology to pet parents in Colorado and Illinois" said Yoav Mordowicz, Co-Founder and Co-CEO at Sploot. "This partnership is a natural extension for our commitment to proactive, science-backed care - and it helps us continue redefining what's possible in everyday veterinary wellness, while enhancing the quality and longevity of pets' lives."
With this partnership, Sploot further reinforces its role as a pioneer in adopting next-generation diagnostics and applying precision medicine to everyday pet care.
"Partnering with Sploot was a natural choice for us," said Franz Mittler, Chief Commercial Officer at DeepScan. "Their forward-thinking approach to veterinary care, combined with our innovative screening test, will empower pet parents with vital information that was previously unavailable in the U.S. market."
About Sploot Veterinary Care
Sploot Veterinary Care is redefining the veterinary experience with a modern, pet-parent-first approach. Operating clinics in Denver, Chicago and Colorado Springs, Sploot offers comprehensive services - including primary, urgent, emergency and specialty care – under one roof. As a FearFree practice, Sploot prioritizes reducing pet stress and anxiety during every visit, ensuring a calm and compassionate environment. Their state-of-the-art facilities are open 8am-8pm, 365 days a year, providing same-day appointments and a seamless digital experience. With a focus on transparency, convenience and exceptional care, Sploot is committed to making veterinary services more accessible and stress-free for both pets and their parents.
More on PrAtlas
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
About DeepScan Diagnostics:
DeepScan Diagnostics is redefining pet healthcare by making early detection accessible, affordable, and transformative. Utilizing advanced, non-invasive cell-free DNA measurements, DeepScan empowers veterinarians and pet parents with precise health screenings, often identifying issues before symptoms appear. With a commitment to extending and enhancing pets' lives through proactive and personalized care, DeepScan is pioneering precision diagnostics and building the largest cfDNA dataset to improve decision-making, treatment options, and peace of mind for both pet parents and veterinary professionals.
Source: Sploot Veterinary Care
Filed Under: Health
0 Comments
Latest on PrAtlas
- VoodooSoft Unveils SiriusLLM: The World's First ChatGPT-Like AI Malware Detection Engine
- This Ain't Press. This Is Pressure — Star Command by RansomXX is Out Now
- An Exclusive VIP Reception Honoring Vocal Prodigy Alliana Lili Yang's Remarkable Achievements and Magazine Cover Spotlight
- Joyce Carol Oates Returns to Hard Case Crime With DOUBLE TROUBLE
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
- IQSTEL Surges Toward $400M Run Rate with $101.5M in Revenue—Reinforces Billion-Dollar Vision Backed by Fintech, AI, and Cybersecurity
- Alpha Modus Files 7th IP Action Against Rackspace Following $3M CEO Investment and Strategic Partnership Expansion
- Mortgage Rates And Demand Are Stuck In A Holding Pattern
- Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
- Keepy Uppy™ by Ollyball Wins Prestigious 2025 Influencer Award from Clamour & The Toy Association; Announces Fall 2025 Launch at Target Stores
- K2 Integrity's U.S. and EMEA Teams Recognized in Chambers and Partners 2025 Guides
- A rare chance to own a multi-family property in the heart of Bay Ridge
- LA Laura Paris Drops Underground Girl Remixes
- Nationally Recognized Hispanic Activist and Businessman, Luis Figueroa, to speak at CPAC Latino 2025, Showcasing Hispanic Leadership in Action
- Holiday Inn Express North Hollywood Burbank Area Announces Conversion to Hampton Inn North Hollywood
- Pray the News Launches to Transform American Christians' Relationship with News
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide
- Lottery.com Inc. Secures $300 Million in Growth Capital, Confirms Nasdaq Compliance & Acquires UAE Sports Incubator Amid High-Profile Brand Exposure
- $750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
- NUFABRX awarded Therapeutic Compression agreement with Premier, Inc